At 7.3% CAGR, Middle East & Africa Poultry Vaccines Market is Projected to be Worth US$ 119.87 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa poultry vaccines market was valued at US$ 68.09 million in 2023 and is anticipated to reach US$ 119.87 million by 2031, registering a CAGR of 7.3% from 2023 to 2031. Rising prevalence of poultry diseases and growing poultry industry are among the critical factors attributed to drive the Middle East & Africa poultry vaccines market growth.

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease-causing huge production losses to the farmers of developing countries that export poultry products.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

On the contrary, vaccination failure and improper handling hamper the growth of Middle East & Africa poultry vaccines market.

Based on type, the Middle East & Africa poultry vaccines market is bifurcated into broiler and layer. The broiler segment held 62.7% market share in 2023, amassing US$ 42.67 million. It is projected to garner US$ 77.01 million by 2031 to register 7.7% CAGR during 2023–2031.

In terms of technology, the Middle East & Africa poultry vaccines market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held 53.3% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 36.28 million. It is projected to garner US$ 64.79 million by 2031 to register 7.5% CAGR during 2023–2031.

By dosage form, the Middle East & Africa poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held 49.3% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 33.55 million. It is projected to garner US$ 61.26 million by 2031 to expand at 7.8% CAGR from 2023 to 2031.

Based on type of disease, the Middle East & Africa poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held 27.6% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 18.80 million. It is predicted to garner US$ 34.90 million by 2031 to expand at 8.0% CAGR between 2023 and 2031.

By route of administration, the Middle East & Africa poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held 40.1% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 27.30 million. It is estimated to garner US$ 50.16 million by 2031 to expand at 7.9% CAGR during 2023–2031.

In terms of end user, the Middle East & Africa poultry vaccines market is categorized into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held 50.2% share of Middle East & Africa hearing aids market in 2023, amassing US$ 34.17 million. It is projected to garner US$ 62.52 million by 2031 to expand at 7.8% CAGR from 2023 to 2031.

Based on country, the Middle East & Africa poultry vaccines market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 71.9% share of Middle East & Africa poultry vaccines market in 2023. It was assessed at US$ 48.98 million in 2023 and is likely to hit US$ 88.33 million by 2031, registering a CAGR of 7.6% during 2023–2031.

Key players operating in the Middle East & Africa poultry vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB, among others.

• In January 2020, Boehringer Ingelheim has launched VAXXITEK HVT+IBD+ND. The vaccines provides a strong immune foundation and optimized protection against Marek's Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com